ADDF-Harrington Scholar Program

Sponsor: Alzheimer’s Drug Discovery Foundation (ADDF)

Award: Up to $600,000 over two years.

Due Date: Letter of Intent: April 23rd, 2021, 5 p.m. EDT. Full Proposal: July 30, 2021, 5 p.m. EDT.

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required (RFA-FD-22-001)

Sponsor: Food and Drug Administration

Due Date: February 15, 2022; February 13, 2024: by 11:59 PM Eastern time.

Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)

Sponsor: National Institute of General Medical Sciences

Due Date: May 26, 2021; May 26, 2022; May 26, 2023. All applications are due by 5 p.m. local time of applicant organization.

Promoting Diversity, Equity and Inclusion in Parkinson’s Disease Research

Sponsor: The Michael J. Fox Foundation for Parkinson's Research

Award: $50,000 up to $400,000 for 18 to 36 months

Due Date: April 21, 2021, 5 p.m. US ET

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) (PA-21-151)

Sponsor: National Institutes of Health

Due Date: January 7, 2024

Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) PAR-21-125)

Sponsor: Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of General Medical Sciences

Award: NIH intends to commit about $3 million in FY2022 to fund an estimated 12-20 awards.

Due Date: June 1, 2021

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) (PAR-21-126)

Sponsor: Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of General Medical Sciences

Award: ORIP intends to commit about $30 million in FY 2022 to fund an estimated 25 HEI awards.

Due Date: June 1, 2021

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) (PAR-21-127)

Sponsor: Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of General Medical Sciences

Award: NIH intends to commit about $35 million in FY 2022 to fund an estimated 75 awards.

Due Date: June 1, 2021

Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination (NOT-NS-21-014)

Sponsor: National Institutes of Health

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) (PAR-21-144)

Sponsor: National Institutes of Health

Due Date: March 17, 2021

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) (PAR-21-145)

Sponsor: National Institutes of Health

Due Date: March 17, 2021

Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required) (RFA-AG-22-011)

Sponsor: National Institute on Aging

Award: NIA intends to commit $4.5 million in total costs in FY 2022 to fund four to six awards.

Due Date: June 17, 2021

Visual Proteomics Imaging RFA

Sponsor: Chan-Zuckerberg initiative

Due Date: Applications close Wednesday, February 17, 2021 at 5 p.m. Pacific Time

NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) (PAR-20-317)

Sponsor: National Institute on Aging

Award: Direct costs up to $375,000 per year may be requested.

Due Date: May 25, 2021; May 25, 2022; May 25, 2023

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) (PAR-21-106)

Sponsor: National Institute on Aging

Due Date: Standard dates apply. The first standard due date for this FOA is June 12, 2021.